Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-30T23:11:51.724Z Has data issue: false hasContentIssue false
  • English
  • Français

Choice of Antibiotic and Risk of Colonization With Vancomycin-Resistant Enterococcus Among Patients Admitted for Treatment of Community-Acquired Pneumonia

Published online by Cambridge University Press:  02 January 2015

John Manzella ,
Ronald Benenson ,
Gene Pellerin ,
James Kellogg ,
Theodore Bell ,
Michelle Robertson  and
Doris Pope
John Manzella*
Affiliation:
Department of Medicine, York Hospital, York, Pennsylvania
Ronald Benenson
Affiliation:
Department of Emergency Medicine, York Hospital, York, Pennsylvania
Gene Pellerin
Affiliation:
Department of Emergency Medicine, York Hospital, York, Pennsylvania
James Kellogg
Affiliation:
Department of Microbiology, York Hospital, York, Pennsylvania
Theodore Bell
Affiliation:
Department of Research, York Hospital, York, Pennsylvania
Michelle Robertson
Affiliation:
Department of Nursing, York Hospital, York, Pennsylvania
Doris Pope
Affiliation:
Department of Infection Control, York Hospital, York, Pennsylvania
*
Department of Medicine, York Hospital, 1001 South George St, York, PA 17405
Get access Rights & Permissions [Opens in a new window]

Abstract

A time-series prospective study of patients admitted to the hospital for treatment of community-acquired pneumonia was undertaken to determine vancomycin-resistant enterococcal perianal colonization rates among patients who received ceftriaxone with or without erythromycin versus those who received levofloxacin. A colonization rate of 16% (8/51) was found in the ceftriaxone-erythromycin group versus 0% (0/52) in the levofloxacin group.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 12 , December 2000 , pp. 789 - 791
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention. Summary of notifiable diseases, United States 1994. MMWR 1994;43:1–80.Google Scholar
2.Bhorade, SM, Christenson, J, Pohlman, AS, Arnow, PM, Hall, JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999;115:1085–1091.Google Scholar
3.Lai, KK, Fontecchio, SA, Kelley, AL, Melvin, ZS, Baker, S. The epidemiology of fecal carriage of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:762–765.Google Scholar
4.Linden, PK, Miller, CB. Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. Diagn Microbial Infect Dis 1999;33:113–120.CrossRefGoogle ScholarPubMed
5.Tucci, V, Haran, MA, Isenberg, HD. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital. Am J Infect Control 1997;25:371–376.Google Scholar
6.Quale, J, Landman, D, Saurina, G, Atwood, E, DiTore, V, Patel, K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020–1025.Google Scholar
7.Bonten, MJ, Slaughter, S, Ambergen, AW, Hayden, MK, van Voorhis, J, Nathan, C, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127–1132.Google Scholar
8.Hayden, MK, Matushek, MG, Trenholme, GM. Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species. Diagn Microbiol Infect Dis 1995;22:349–352.Google Scholar
9.Nilsson-Ehle, I, Nord, CE, Ursing, B. Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections. Scand J Infect Dis 1985;17:77–82.Google Scholar
10.Murray, BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710–721.Google Scholar